Key clinical point: A new concept in coronary stent design shows early promise.
Major finding: There were no cases of target lesion revascularization, device thrombosis, or strut fracture within 12 months after implantation of the DynamX Bioadaptor coronary stent in a small pilot study.
Study details: This was an uncontrolled study of the performance of a novel coronary stent in 50 patients followed for 1 year.
Disclosures: The presenter reported serving as a consultant to Elixir Medical, the study sponsor.
Verheye S. EuroPCR 2020.